Argos Therapeutics

Share on: 
Description: 

Develops Arcelis,®  a precision immunotherapy technology that captures the spectrum of mutated (or neoantigens) and variant antigens that are specific to each patient’s individual disease. It was designed to overcome immunosuppression by enabling specifically targeted, durable memory T-cells without adjuvants that may be associated with toxicity

Location(s): 
Durham NC
United States